| Literature DB >> 32414199 |
Marco Portelli1, Angela Militi1, Antonino Lo Giudice1, Roberto Lo Giudice1, Lorenzo Rustico1, Rosamaria Fastuca2, Riccardo Nucera1.
Abstract
Background: Cone beam computed tomography (CBCT) is often used in different fields of dental science, especially in complex anatomical districts like the endodontic one. The aim of this study is to propose a low-dose CBCT protocol useful in cases of endodontic lesions.Entities:
Keywords: 3D imaging; endodontic lesions; low-dose cone beam
Year: 2020 PMID: 32414199 PMCID: PMC7345315 DOI: 10.3390/dj8020051
Source DB: PubMed Journal: Dent J (Basel) ISSN: 2304-6767
Figure 1Head–neck phantom positioned in the cone beam computed tomography (CBCT).
Descriptive statistics for absorbed dose values.
| ABSORBED DOSE (mGy) | ||||
|---|---|---|---|---|
| MIN | MAX | MEDIUM | DS | |
| Bone Marrow | 0.10 | 0.16 | 0.13 | 0.03 |
| Salivary Glands | 0.40 | 0.47 | 0.0435 | 0.035 |
| Brain | 0.01 | 0.11 | 0.06 | 0.05 |
| Tyroid | 0.10 | 0.12 | 0.11 | 0.01 |
| Esophagus | 0.04 | 0.05 | 0.45 | 0.005 |
| Oral Mucosa | 0.32 | 0.36 | 0.34 | 0.02 |
| Extra-Toracic Airway | 0.14 | 0.16 | 0.15 | 0.009 |
| Lymphnodes | 0.21 | 0.22 | 0.215 | 0.005 |
| Skin | 0.1052 | 0.1061 | 0.1056 | 0.00045 |
| Muscle | 0.21 | 0.22 | 0.215 | 0.005 |
| Bone Surface | 0.10 | 0.16 | 0.13 | 0.03 |
Descriptive statistics for equivalent dose values.
| EQUIVALENT DOSE (µ SV) | ||||
|---|---|---|---|---|
| MIN | MAX | MEDIUM | DS | |
| Bone Marrow | 17.52 | 26.63 | 21.89 | 4.555 |
| Salivary Glands | 403.97 | 477.68 | 440.825 | 36.885 |
| Brain | 112.83 | 119.58 | 116.205 | 3.375 |
| Tyroid | 100.46 | 123.01 | 111.73 | 11.275 |
| Esophagus | 4.43 | 5.59 | 5.01 | 0.58 |
| Oral Mucosa | 326.46 | 366.08 | 346.27 | 19.81 |
| Extra-Toracic Airway | 149.88 | 162.19 | 156.035 | 6.154 |
| Lymphnodes | 10.56 | 11.20 | 10.88 | 0.32 |
| Skin | 5.26 | 5.31 | 5.285 | 0.024 |
| Muscle | 10.56 | 11.20 | 10.88 | 0.32 |
| Bone Surface | 34.99 | 53.18 | 44.085 | 9.095 |
Descriptive statistics for effective dose values.
| EFFECTIVE DOSE (µ SV) | ||||
|---|---|---|---|---|
| MIN | MAX | MEDIUM | DS | |
| Bone Marrow | 0.17 | 0.26 | 0.215 | 0.045 |
| Salivary Glands | 4.039 | 4.77 | 4.4045 | 0.3655 |
| Brain | 0.38 | 0.45 | 0.415 | 0.035 |
| Tyroid | 4.01 | 4.92 | 4.465 | 0.455 |
| Esophagus | 0.17 | 0.22 | 0.195 | 0.025 |
| Oral Mucosa | 39.17 | 43.92 | 41.545 | 2.375 |
| Extra-Toracic Airway | 17.98 | 19.46 | 18.72 | 0.74 |
| Lymphnodes | 1.26 | 1.34 | 1.3 | 0.040 |
| Skin | 0.052 | 0.053 | 0.0525 | 0.0005 |
| Muscle | 1.26 | 1.34 | 1.3 | 0.040 |
| Bone Surface | 0.34 | 0.53 | 0.435 | 0.095 |
Figure 2Maxillary apical granuloma in 3D, Sagittal, and Panorex views.
Figure 3Mandibular periapical cyst in 3D, Sagittal, and Panorex views.
Age, gender, and clinical characteristics of the patients.
| Patient | Age | Gender | Clinical Characteristics |
|---|---|---|---|
| 1 | 46 | Female | Apical Granuloma |
| 2 | 31 | Female | Periapical Cyst |
| 3 | 56 | Male | Apical Granuloma |
| 4 | 49 | Male | Apical Granuloma |
| 5 | 27 | Male | Periapical Cyst |
| 6 | 52 | Female | Periapical Cyst |
| 7 | 48 | Male | Apical Granuloma |
| 8 | 61 | Male | Periapical Cyst |
| 9 | 43 | Female | Apical Granuloma |
| 10 | 39 | Male | Apical Granuloma |
Image quality evaluation scores.
| IMAGE QUALITY EVALUATION SCORES | |
|---|---|
| Endodontist I | 7 |
| Endodontist II | 6 |
| Endodontist III | 7 |
| Endodontist IV | 8 |
| Endodontist V | 7 |
| MEAN VALUE | 7.0 |